Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer

by Michael A. O'Donnell and Mohamad Abou Chakra , Medical XpressNMIBC: non-muscle invasive bladder cancer; BCG: Bacillus Calmette-Guérin; Gem: gemcitabine; Doce: docetaxel. Parts of the figure wer

Updated on: April 02,2024

Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer

by Michael A. O'Donnell and Mohamad Abou Chakra , Medical XpressNMIBC: non-muscle invasive bladder cancer; BCG: Bacillus Calmette-Guérin; Gem: gemcitabine; Doce: docetaxel. Parts of the figure wer

Updated on:April 02,2024

Obesity is increasing people's risk of cancer. Why?

by Nancy Fliesler,Children's Hospital BostonAcomposite image representing a dormant breast tumor in the mammary fat pad of an obese mouse that is recruiting new blood vessels. Credit:

Updated on: December 22,2023

Obesity is increasing people's risk of cancer. Why?

by Nancy Fliesler,Children's Hospital BostonAcomposite image representing a dormant breast tumor in the mammary fat pad of an obese mouse that is recruiting new blood vessels. Credit:

Updated on:December 22,2023

Low-fat diet could be key to stopping cancer growth

by South Australian Health and Medical Research Institute (SAHMRI)Credit: Dan Gold on UnsplashNew research has found food could play a major role in stopping the growth of some cancers.It was previous

Updated on: December 20,2023

Low-fat diet could be key to stopping cancer growth

by South Australian Health and Medical Research Institute (SAHMRI)Credit: Dan Gold on UnsplashNew research has found food could play a major role in stopping the growth of some cancers.It was previous

Updated on:December 20,2023

Scientists develop new treatment with potential to tackle most common form of childhood cancer

Updated on: June 14,2025

Scientists develop new treatment with potential to tackle most common form of childhood cancer

Updated on:June 14,2025

AI-Assisted Histopathology: Refining the Distinction Between Sebaceous and Squamous Cell Carcinoma of the Eyelid

Updated on: August 30,2025

AI-Assisted Histopathology: Refining the Distinction Between Sebaceous and Squamous Cell Carcinoma of the Eyelid

Updated on:August 30,2025

Research into use of diabetes medication for treatment of metastatic prostate cancer

byMedical University of ViennaCredit: AI-generated imagePatients with localized prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of

Updated on: January 04,2024

Research into use of diabetes medication for treatment of metastatic prostate cancer

byMedical University of ViennaCredit: AI-generated imagePatients with localized prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of

Updated on:January 04,2024

Head and neck cancer survivors at increased risk of suicide

by Maggie Rotermund,Saint Louis UniversityNosayaba Osazuwa-Peters, BDS, PH.D., MPH, is an assistant professor of otolaryngology at Saint Louis University School of Medicine and faculty member at

Updated on: December 18,2023

Head and neck cancer survivors at increased risk of suicide

by Maggie Rotermund,Saint Louis UniversityNosayaba Osazuwa-Peters, BDS, PH.D., MPH, is an assistant professor of otolaryngology at Saint Louis University School of Medicine and faculty member at

Updated on:December 18,2023

Polygenic risk scores may miss the mark when predicting aggressive prostate cancers

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainAccording to a research letter published inJAMA Internal Medicine, prostate cancer screening frequently results in biopsies tha

Updated on: December 21,2023

Polygenic risk scores may miss the mark when predicting aggressive prostate cancers

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainAccording to a research letter published inJAMA Internal Medicine, prostate cancer screening frequently results in biopsies tha

Updated on:December 21,2023

Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

byUniversity of Texas M. D. Anderson Cancer CenterCancer cell during cell division. Credit: National Institutes of HealthA study at The University of Texas MD Anderson Cancer Center demonstrated

Updated on: December 22,2023

Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

byUniversity of Texas M. D. Anderson Cancer CenterCancer cell during cell division. Credit: National Institutes of HealthA study at The University of Texas MD Anderson Cancer Center demonstrated

Updated on:December 22,2023

Protein movement reveals brain tumor's weak spot

by Annika Lund,Karolinska InstitutetCredit: Unsplash/CC0 Public DomainProteins do not have a single shape, but are more like dynamic robots. But—how do they actually move? And what does this tel

Updated on: December 20,2023

Protein movement reveals brain tumor's weak spot

by Annika Lund,Karolinska InstitutetCredit: Unsplash/CC0 Public DomainProteins do not have a single shape, but are more like dynamic robots. But—how do they actually move? And what does this tel

Updated on:December 20,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on: December 26,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on:December 26,2023

Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

byNYU Langone HealthMouse pancreatic tumor cells (red) produce the signaling protein IL-1β (green) to support cancer growth by suppressing the immune system. Credit: NYU Grossman School of Medic

Updated on: December 22,2023

Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

byNYU Langone HealthMouse pancreatic tumor cells (red) produce the signaling protein IL-1β (green) to support cancer growth by suppressing the immune system. Credit: NYU Grossman School of Medic

Updated on:December 22,2023